Pharmaceuticals have brought immense health benefits to developing countries, but one third of the world’s population does not have access to existing essential drugs. The Commission on Health Research for Development (1990) showed that less than 10 per cent of global health research is directed towards diseases that afflict 90% of the world’s population. IPRs in pharmaceuticals have two principal areas of impact which affect public health. First, there is the issue of access, where discussion focuses on the links between IPRs, exclusion of competitors and the availability and pricing of new medicines. Second, there is the issue of incentive innovation, where discussion focuses on the role of IPRs in motivating R&D and marketing of new drugs and the effect of IPRs on R&D expenditure and its allocation across diseases, countries and organizations.
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Pharmaceuticals have brought immense health benefits to developing countries, but one third of the world's population does not have access to existing essential drugs. The Commission on Health Research for Development (1990) showed that less than 10 per cent of global health research is directed towards diseases that afflict 90% of the world's population. IPRs in pharmaceuticals have two principal areas of impact which affect public health. First, there is the issue of access, where discussion focuses on the links between IPRs, exclusion of competitors and the availability and pricing of new medicines. Second, there is the issue of incentive innovation, where discussion focuses on the role of IPRs in motivating R&D and marketing of new drugs and the effect of IPRs on R&D expenditure and its allocation across diseases, countries and organizations. 64 pp. Englisch. Codice articolo 9786139851003
Quantità: 2 disponibili
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. Codice articolo 26390073021
Quantità: 4 disponibili
Da: Majestic Books, Hounslow, Regno Unito
Condizione: New. Print on Demand. Codice articolo 389526882
Quantità: 4 disponibili
Da: Biblios, Frankfurt am main, HESSE, Germania
Condizione: New. PRINT ON DEMAND. Codice articolo 18390073015
Quantità: 4 disponibili
Da: moluna, Greven, Germania
Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Goyal AnjuDr Anju Goyal is Professor in Pharmaceutical Chemistry and Head of Department of Pharmaceutical Quality Assurance at BN Institute of Pharmaceutical Sciences, Udaipur. Dr Kamal Singh Rathore is Head of Department at Pharmace. Codice articolo 385874291
Quantità: Più di 20 disponibili
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Pharmaceuticals have brought immense health benefits to developing countries, but one third of the world's population does not have access to existing essential drugs. The Commission on Health Research for Development (1990) showed that less than 10 per cent of global health research is directed towards diseases that afflict 90% of the world's population. IPRs in pharmaceuticals have two principal areas of impact which affect public health. First, there is the issue of access, where discussion focuses on the links between IPRs, exclusion of competitors and the availability and pricing of new medicines. Second, there is the issue of incentive innovation, where discussion focuses on the role of IPRs in motivating R&D and marketing of new drugs and the effect of IPRs on R&D expenditure and its allocation across diseases, countries and organizations.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 64 pp. Englisch. Codice articolo 9786139851003
Quantità: 1 disponibili
Da: AHA-BUCH GmbH, Einbeck, Germania
Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Pharmaceuticals have brought immense health benefits to developing countries, but one third of the world's population does not have access to existing essential drugs. The Commission on Health Research for Development (1990) showed that less than 10 per cent of global health research is directed towards diseases that afflict 90% of the world's population. IPRs in pharmaceuticals have two principal areas of impact which affect public health. First, there is the issue of access, where discussion focuses on the links between IPRs, exclusion of competitors and the availability and pricing of new medicines. Second, there is the issue of incentive innovation, where discussion focuses on the role of IPRs in motivating R&D and marketing of new drugs and the effect of IPRs on R&D expenditure and its allocation across diseases, countries and organizations. Codice articolo 9786139851003
Quantità: 1 disponibili
Da: preigu, Osnabrück, Germania
Taschenbuch. Condizione: Neu. Intellectual Property Rights: Abstract Book | Anju Goyal (u. a.) | Taschenbuch | 64 S. | Englisch | 2018 | LAP LAMBERT Academic Publishing | EAN 9786139851003 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. Codice articolo 114111812
Quantità: 5 disponibili
Da: Mispah books, Redhill, SURRE, Regno Unito
paperback. Condizione: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book. Codice articolo ERICA82961398510096
Quantità: 1 disponibili